MAPT and Alzheimer disease: In this study, we present the first evidence of pathogenic tau inclusions, specifically pS396-tau and Oligo-tau, within RBPMS-positive RGCs, concomitant with ganglion cell loss (~ 50%) in the retinas of donor patients with MCI (due to AD) and AD dementia.